MedPath

A study to see the effect of two drugs, norepinephrine and mephentermine for maintenance of blood pressure during caesarean section.

Not Applicable
Completed
Conditions
Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Registration Number
CTRI/2019/06/019652
Lead Sponsor
Dr PJ Shah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
297
Inclusion Criteria

1. ASA Physical status â??Ð?Ð?

2. Singleton pregnancy

3. Term Pregnancy

4. Elective Cesarean Delivery

5. Weight 50-100kg

6. Height 140-180 cm

7. Age 18-35 years

Exclusion Criteria

1.Pre-existing or Pregnancy induced Hypertension

2.Known fetal abnormality

3.Cardiovascular or Cerebrovascular disease

4.Gestational Diabetes Mellitus

5.Renal Impairment

6.Allergy to Norepinephrine & Mephentermine

7. Medication- MAO Inhibitors or TCA

8.Intraoperative use of uterotonic other than oxytocin

9.Presence of mesenteric or peripheral vascular thrombosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maternal Systolic Blood PressureTimepoint: At every 2 minutes after administration of spinal anaesthesia till 20 minutes and every 5 minutes there after till completion of surgery.
Secondary Outcome Measures
NameTimeMethod
Maternal diastolic blood pressure,Maternal mean blood pressure,Maternal heart rate,Total dose of vasopressor required for correction of hypotension <br/ ><br>Timepoint: At every 2 minutes after administration of spinal anaesthesia till 20 minutes and every 5 minutes there after till completion of surgery.
© Copyright 2025. All Rights Reserved by MedPath